Sera Prognostics (SERA) Return on Sales Growth (1y) (2021 - 2026)
Sera Prognostics (SERA) Return on Sales Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | 0.00 |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 0.00 |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | 0.00 |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | 0.00 |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | 0.00 |
| 10 | Sera Prognostics | 107.05 Mn | 107.05 Mn | -28,000.00 | -552.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -552.00 |
| Dec 31, 2025 | -109.00 |
| Sep 30, 2025 | -505.00 |
| Jun 30, 2025 | -364.00 |
| Mar 31, 2025 | -50.00 |
| Dec 31, 2024 | -208.00 |
| Sep 30, 2024 | -100.00 |
| Jun 30, 2024 | -271.00 |
| Mar 31, 2024 | -60.00 |
| Dec 31, 2023 | -22.00 |
| Sep 30, 2023 | -58.00 |
| Jun 30, 2023 | 59.00 |
| Mar 31, 2023 | 214.00 |
| Dec 31, 2022 | 322.00 |
| Sep 30, 2022 | 301.00 |
| Jun 30, 2022 | 216.00 |
| Mar 31, 2022 | 234.00 |
| Dec 31, 2021 | 403.00 |
| Sep 30, 2021 | 584.00 |
| Jun 30, 2021 | 414.00 |